Table 5 characteristics of the tumor in relation to sensitivity to chemotherapeutic agents
Compounds | Sensitive patients | BCLC | Child-Pugh | Tumor Number | Tumor differentiation | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
A | B | A | B | Single | 2~3 | Well | moderate | poorly | |||
CDDP | IC max | 8 | 6 | 2 | 8 | – | 5 | 3 | 7 | 1 | – |
IC 50 | 3 | 3 | – | 3 | – | 2 | 1 | 3 | – | – | |
EPI | IC max | 9 | 5 | 4 | 9 | – | 6 | 3 | 4 | 5 | – |
IC 50 | 4 | 3 | 1 | 4 | – | 2 | 2 | 2 | 2 | – | |
L-OHP | IC max | 5 | 5 | – | 5 | – | 3 | 2 | 5 | 1 | – |
IC 50 | 2 | 2 | – | 2 | – | 1 | 1 | 2 | – | – | |
5-FU | IC max | – | – | – | – | – | – | – | – | – | – |
IC 50 | – | – | – | – | – | – | – | – | – | – | |
PAC | IC max | – | – | – | – | – | – | – | – | – | – |
IC 50 | – | – | – | – | – | – | – | – | – | – | |